Overexpression of oxidored-nitro domain containing protein 1 inhibits human nasopharyngeal carcinoma and cervical cancer cell proliferation and induces apoptosis: Involvement of mitochondrial apoptotic pathways

Oncology Reports

Volumn 29, Issue 1, 2013, Pages 79-86

  Ouyang, Jue ^a,c   Wu, Minghua ^a,c   Huang, Chen ^a,b   Cao, Li ^a   Li, Guiyuan ^a,c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b PEKING UNIVERSITY   (China)

^c Hunan Key Laboratory of Nonresolving Inflammation and Cancer   (China)

Author keywords

Apoptosis; Cervical cancer; Mitochondria; Nasopharyngeal carcinoma; Oxidored nitro domain containing protein 1; Proliferation

Indexed keywords

CYTOPLASM PROTEIN; NOR1 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; ENDOPLASMIC RETICULUM; EXPRESSION VECTOR; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOCHONDRION; NASOPHARYNX CARCINOMA; NOR1 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TUMOR SUPPRESSOR GENE; UPREGULATION; UTERINE CERVIX CANCER;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL CYCLE; CELL PROLIFERATION; ENDOPLASMIC RETICULUM; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IN SITU HYBRIDIZATION; MEMBRANE TRANSPORT PROTEINS; MITOCHONDRIA; NASOPHARYNGEAL NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 84872874478     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2101     Document Type: Article

References (26)

1. Nie X, Zhang B, Li X, et al: Cloning, expression, and mutation analysis of NOR1, a novel human gene down-regulated in HNE1 nasopharyngeal carcinoma cell line. J Cancer Res Clin Oncol 129: 410-414, 2003.
2. Xiang B, Yi M, Wang L, et al: Preparation of polyclonal antibody specific for NOR1 and detection of its expression pattern in human tissues and nasopharyngeal carcinoma. Acta Biochim Biophys Sin 41: 754-762, 2009.
3. Li W, Li X, Wang W, et al: NOR1 is an HSF1- and NRF1-regulated putative tumor suppressor inactivated by promoter hypermethylation in nasopharyngeal carcinoma. Carcinogenesis 32: 1305-1314, 2011.
4. Kroeger H, Jelinek J, Estecio MR, et al: Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse. Blood 112: 1366-1373, 2008.
5. Calmels S, Ohshima H, Rosenkranz H, McCoy E and Bartsch H: Biochemical studies on the catalysis of nitrosation by bacteria. Carcinogenesis 8: 1085-1088, 1987.
6. Reznik G, Mohr U and Kruger FW: Carcinogenic effects of Di-n-propylnitrosamine, beta-hydroxypropyl-n-propylnitrosamine, and methyl-n-propylnitrosamine on Sprague-Dawlay rats. J Natl Cancer Inst 54: 937-943, 1975.
7. Lijinsky W and Taylor HW: Carcinogenicity of methylated nitrosopiperidines. Int J Cancer 16: 318-322, 1975.
8. Chang ET and Adami HO: The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 15: 1765-1777, 2006.
9. Lo KW, To KF and Huang DP: Focus on nasopharyngeal carcinoma. Cancer Cell 5: 423-428, 2004.
10. Lin YP, Nicholas K, Ball FR, McLaughlin B and Bishai FR: Detection of Norwalk-like virus and specific antibody by immune-electron microscopy with colloidal gold immune complexes. J Virol Methods 35: 237-253, 1991.
11. Yan J, Fang Y and Liang Q: Frequent chromosomal gain of 4q and loss of 1p in primary nasopharyngeal carcinoma. Zhonghua Zhong Liu Za Zhi 23: 208-210, 2001 (In Chinese).
12. Fang Y, Guan X, Guo Y, et al: Analysis of genetic alterations in primary nasopharyngeal carcinoma by comparative genomic hybridization. Genes Chromosomes Cancer 30: 254-260, 2001.
13. Shao JY, Wang HY, Huang XM, et al: Genome-wide allelotype analysis of sporadic primary nasopharyngeal carcinoma from southern China. Int J Oncol 17: 1267-1275, 2000.
14. Lo KW, Teo PM, Hui AB, et al: High resolution allelotype of microdissected primary nasopharyngeal carcinoma. Cancer Res 60: 3348-3353, 2000.
15. Gadji M, Fortin D, Tsanaclis AM and Drouin R: Is the 1p/19q deletion a diagnostic marker of oligodendrogliomas? Cancer Genet Cytogenet 194: 12-22, 2009.
16. Tews B, Roerig P, Hartmann C, et al: Hypermethylation and transcriptional downregulation of the CITED4 gene at 1p34. 2 in oligodendroglial tumours with allelic losses on 1p and 19q. Oncogene 26: 5010-5016, 2007.
17. Chunder N, Mandal S, Basu D, Roy A, Roychoudhury S and Panda CK: Deletion mapping of chromosome 1 in early onset and late onset breast tumors - a comparative study in eastern India. Pathol Res Pract 199: 313-321, 2003.
18. Jung JY and Kim WJ: Involvement of mitochondrial- and Fas-mediated dual mechanism in CoCl2-induced apoptosis of rat PC12 cells. Neurosci Lett 371: 85-90, 2004.
19. Gross A, McDonnell JM and Korsmeyer SJ: BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13: 1899-1911, 1999.
20. Kruse JP and Gu W: Modes of p53 regulation. Cell 137: 609-622, 2009.
21. Wang CY, Mayo MW, Korneluk RG, Goeddel DV and Baldwin AS Jr.: NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281: 1680-1683, 1998.
22. Kucharczak J, Simmons MJ, Fan Y and Gelinas C: To be, or not to be: NF-kappaB is the answer - role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene 22: 8961-8982, 2003.
23. Stoffel A and Levine AJ: Actvation of NF-kappaB by the API2/MALT1 fusions inhibits p53 dependant but not FAS induced apoptosis: a directional link between NF-kappaB and p53. Cell Cycle 3: 1017-1020, 2004.
24. Yin Y, Chen W, Tang C, et al: NF-kappaB, JNK and p53 pathways are involved in tubeimoside-1-induced apoptosis in HepG2 cells with oxidative stress and G(2)/M cell cycle arrest. Food Chem Toxicol 49: 3046-3054, 2011.
25. Maldonado ME, Bousserouel S, Gosse F, Lobstein A and Raul F: Implication of NF-kappaB and p53 in the expression of TRAIL-death receptors and apoptosis by apple procyanidins in human metastatic SW620 cells. Biomedica 30: 577-586, 2010.
26. Pratheeshkumar P, Sheeja K and Kuttan G: Andrographolide induces apoptosis in B16F-10 melanoma cells by inhibiting NF-kappaB-mediated bcl-2 activation and modulating p53-induced caspase-3 gene expression. Immunopharmacol Immunotoxicol 34: 143-151, 2012.